LOPHOS HOLDINGS INC.

Press Releases Lophos Holdings Inc.

Equities

MESC

CA5439371066

Market Closed - Canadian Securities Exchange Other stock markets 16:39:29 24/05/2024 BST			5-day change	1st Jan Change
0.05 ^CAD	-9.09%		-9.09%	+25.00%

04-15	ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	CI
04-15	ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lophos Pharmaceuticals Corp. Receives Traditional Blessing for Napanee Site in Honor of Indigenous Heritage	05-15	NE
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com	05-06	AQ
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol	05-02	AQ
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds	04-25	AQ
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy	04-17	AQ
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership	04-15	AQ
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.	04-15	AQ
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan	03-28	AQ
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy	03-05	AQ
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting	02-28	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)	02-14	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol	02-08	AQ
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)	01-31	AQ
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation	01-23	AQ
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	11-22	AQ
Lophos Secures Game-Changing Controlled Substance Dealer's License with the Expertise of Canalytica Corp.	10/10/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer